mitomycin has been researched along with Cataract, Membranous in 100 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the clinical outcome of eyes which underwent primary trabeculectomy with adjunctive mitomycin C (MMC) for primary glaucoma." | 8.79 | Mitomycin C primary trabeculectomy in primary glaucoma of white patients. ( Nuijts, RM; Vernimmen, RC; Webers, CA, 1997) |
| "We report on a 56-year-old male with primary open-angle glaucoma who underwent mitomycin C augmented canaloplasty enabling filtration in the right eye after cataract surgery combined with a Schlemm's canal microstent 3 years previously." | 8.12 | Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation. ( Elksne, E; Mercieca, K; Prokosch-Willing, V, 2022) |
| "To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy." | 8.12 | The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022) |
| "Glaucoma surgery with the PSM and mitomycin C was efficacious and safe in the short term, either alone or in combination with cataract surgery, and may be considered a surgical option for lowering IOP in primary open angle glaucoma." | 8.12 | Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022) |
| " It was the aim of this study to investigate the therapeutic success of Xen45 gel stents as a stand-alone technique (Xen) and combined with cataract surgery (XenPhaco), and with antimetabolites (mitomycin C, MMC) in open-angle glaucoma patients." | 8.02 | Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients. ( Denkel, L; Hohberger, B; Lämmer, R, 2021) |
| "To compare posterior capsule opacification (PCO) in rabbits who undergo cataract surgery and receive either mitomycin-C (MMC) or distilled water (DW) during sealed-capsule irrigation (SCI)." | 7.74 | Comparison of posterior capsule opacification in rabbits receiving either mitomycin-C or distilled water for sealed-capsule irrigation during cataract surgery. ( Choi, JS; Joo, CK; Kim, JH; Kim, SY, 2007) |
| "With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes." | 7.73 | Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006) |
| "To characterise changes in ocular dimensions after combined cataract operation and trabeculectomy with mitomycin C using separate incisions (combined operation)." | 7.73 | Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions. ( Caprioli, J; Law, SK; Mansury, AM; Vasudev, D, 2005) |
| "To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery." | 7.72 | Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery. ( Bagga, H; Gothwal, VK; Mandal, AK; Nanda, AK; Nutheti, R, 2003) |
| "To present the clinical and histologic findings of a patient in whom intumescent cataract developed after successful topical mitomycin-C (MMC) chemotherapy for conjunctival melanoma originating from primary acquired conjunctival melanosis (PAM) with atypia." | 7.72 | Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. ( Horvat, R; Lukas, JR; Sacu, S; Ségur-Eltz, N; Zehetmayer, M, 2003) |
| "Patients with both cataract and glaucoma underwent combined mitomycin C trabeculectomy, extracapsular cataract extraction, and intraocular lens implantation." | 7.69 | One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. ( Bueche, MJ; Feuer, WJ; Grajewski, AL; Joos, KM; Palmberg, PF, 1995) |
| "The use of topical mitomycin (mitomycin-C) as a medical adjunct to pterygium and glaucoma surgery is increasing." | 7.68 | Serious complications of topical mitomycin-C after pterygium surgery. ( Foster, CS; Martin, NF; Pfister, RR; Rubinfeld, RS; Speaker, MG; Stein, RM; Stoleru, S; Talley, AR, 1992) |
| "The mean intraocular pressures were significantly (P < ." | 6.69 | Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C. ( Bendel, RE; Hughes, BA; Juzych, MS; Kim, C; Lemon, LC; Shin, DH, 1998) |
| "Mitomycin C could cause the degeneration of lens epithelial cells." | 5.31 | [The inhibitory effect of mitomycin C applied by intracapsular method on rabbit lens epithelial cells: an experimental study of after-cataract]. ( Huang, J; Liu, Y; Zheng, D; Zheng, H, 2001) |
| "In this preliminary study, diclofenac sodium is at least as good as topical dexamethasone phosphate for glaucoma patients undergoing two-site combined phacotrabeculectomy with mitomycin C." | 5.17 | Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C. ( Goldenfeld, M; Kalev-Landoi, M; Katz, G; Levkovitch-Verbin, H, 2013) |
| "To compare phacoemulsification versus trabeculectomy with adjunctive mitomycin C in medically uncontrolled chronic angle-closure glaucoma (CACG) without cataract." | 5.17 | Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. ( Baig, N; Kwong, YY; Lam, DS; Leung, DY; Li, FC; Tham, CC, 2013) |
| "Combined phacotrabeculectomy with adjunctive mitomycin C is more effective than phacoemulsification alone in controlling IOP in medically uncontrolled CACG eyes with coexisting cataract." | 5.14 | Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. ( Chan, JC; Chiu, TY; Kwong, YY; Lai, JS; Lam, DS; Lam, SW; Leung, DY; Li, FC; Tham, CC, 2009) |
| "Combined phacotrabeculectomy with adjunctive mitomycin C may be marginally more effective than phacoemulsification alone in controlling IOP in medically controlled CACG eyes with coexisting cataract." | 5.13 | Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. ( Chan, CH; Chan, JC; Chi, CC; Chiu, TY; Kwong, YY; Lai, JS; Lam, DS; Lam, SW; Leung, DY; Li, FC; Poon, AS; Tham, CC; Yick, DW, 2008) |
| "To compare the intraocular pressure (IOP)-lowering effect of combined viscocanalostomy and phacoemulsification and combined trabeculectomy and phacoemulsification with mitomycin C in eyes with primary open-angle glaucoma." | 5.12 | Randomized comparison of the intraocular pressure-lowering effect of phacoviscocanalostomy and phacotrabeculectomy. ( Kobayashi, H; Kobayashi, K, 2007) |
| "Adjunctive subconjunctival mitomycin C did not further improve the final intraocular pressure outcome of the primary trabeculectomy combined with phacoemulsification and intraocular lens implantation in patients with primary open-angle glaucoma." | 5.08 | Adjunctive subconjunctival mitomycin C in glaucoma triple procedure. ( Hughes, BA; Juzych, MS; Kim, C; Reed, SY; Shin, DH; Simone, PA; Song, MS, 1995) |
| "The preponderance of evidence from the literature suggests a small (2-4 mmHg) benefit from the use of mitomycin-C (MMC), but not 5-fluorouracil (5-FU), in combined cataract and glaucoma surgery (evidence grade B)." | 4.81 | Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review. ( Bass, EB; Congdon, N; Friedman, DS; Jampel, HD; Kempen, JH; Levkovitch-Verbin, H; Lubomski, LH; Quigley, H; Robinson, KA, 2002) |
| "To evaluate the clinical outcome of eyes which underwent primary trabeculectomy with adjunctive mitomycin C (MMC) for primary glaucoma." | 4.79 | Mitomycin C primary trabeculectomy in primary glaucoma of white patients. ( Nuijts, RM; Vernimmen, RC; Webers, CA, 1997) |
| " To assess the influence of cataract surgery following TE, eyes which underwent cataract surgery at least 6 months after TE were matched 1:3 by sex and age to eyes who did not undergo cataract surgery during the follow-up period." | 4.31 | Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study. ( Hoffmann, EM; Kianusch, K; Pfeiffer, N; Schuster, AK; Stingl, J; Wagner, FM, 2023) |
| "To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy." | 4.12 | The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022) |
| "Glaucoma surgery with the PSM and mitomycin C was efficacious and safe in the short term, either alone or in combination with cataract surgery, and may be considered a surgical option for lowering IOP in primary open angle glaucoma." | 4.12 | Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022) |
| "We report on a 56-year-old male with primary open-angle glaucoma who underwent mitomycin C augmented canaloplasty enabling filtration in the right eye after cataract surgery combined with a Schlemm's canal microstent 3 years previously." | 4.12 | Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation. ( Elksne, E; Mercieca, K; Prokosch-Willing, V, 2022) |
| " Trabeculectomy with or without augmentation with Mitomycin C(MMC) was the first-choice glaucoma incisional surgery for 96." | 4.12 | Surgical trends in glaucoma management: The current Indian scenario. ( Bhartiya, S; Ichhpujani, P; Kalra, G; Kumar, S; Singla, E, 2022) |
| "Sixty eyes of 60 patients complaining of primary open angle glaucoma and cataract, undergoing phaco-trabeculectomy, were distributed into three groups: group I: surgery was augmented with mitomycin C, group II with porcine extracellular matrix, and group III with porcine extracellular matrix combined with low dose mitomycin C." | 4.02 | The role of mitomycin C and porcine extracellular matrix in phacotrabeculectomy. ( Hamdi, IM; Hamdi, MM, 2021) |
| " It was the aim of this study to investigate the therapeutic success of Xen45 gel stents as a stand-alone technique (Xen) and combined with cataract surgery (XenPhaco), and with antimetabolites (mitomycin C, MMC) in open-angle glaucoma patients." | 4.02 | Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients. ( Denkel, L; Hohberger, B; Lämmer, R, 2021) |
| "To estimate the incidence and predisposing factors for cataract extraction (CE) after Deep Sclerectomy (DS) with Mitomycin-C (MMC) and its effect on intraocular pressure (IOP) control." | 3.91 | Cataract extraction after deep sclerectomy and its effect on intraocular pressure control. ( Anand, N; Darcy, K; Mercieca, K; Perumal, D, 2019) |
| "To evaluate the influence of phacoemulsification on intraocular pressure (IOP) control and survival of mitomycin C (MMC)-enhanced trabeculectomy in uveitic glaucoma (UG)." | 3.85 | The Influence of Phacoemulsification on Intraocular Pressure Control and Trabeculectomy Survival in Uveitic Glaucoma. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2017) |
| "To determine the occurrence of intraoperative and postoperative complications up to three years after primary phacotrabeculectomy with intraoperative use of Mitomycin C (MMC) in primary open angle (POAG) and primary angle closure glaucoma (PACG) patients, and the effect of postoperative complications on surgical outcome." | 3.81 | Complications and outcomes of primary phacotrabeculectomy with mitomycin C in a multi-ethnic asian population. ( Aquino, MC; Chen, DZ; Chew, P; Koh, V; Sng, C, 2015) |
| " Data included patient demographics, pre- and postoperative intraocular pressure (IOP), use of mitomycin C (MMC), spacer device implantation, and follow-up details including surgical success rates." | 3.81 | Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study. ( Anand, N; Mercieca, K; Shevade, B, 2015) |
| "To compare the incidence of upper eyelid blepharoptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification surgeries and the relationship of bleb morphology to the incidence of ptosis." | 3.81 | Comparison of incidence of ptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification. ( Amrith, S; Chew, PT; Koh, V; Tatsios, J, 2015) |
| "To compare posterior capsule opacification (PCO) in rabbits who undergo cataract surgery and receive either mitomycin-C (MMC) or distilled water (DW) during sealed-capsule irrigation (SCI)." | 3.74 | Comparison of posterior capsule opacification in rabbits receiving either mitomycin-C or distilled water for sealed-capsule irrigation during cataract surgery. ( Choi, JS; Joo, CK; Kim, JH; Kim, SY, 2007) |
| "To determine the efficacy and safety of trabeculectomy with mitomycin-C (trabMMC) compared with that of single-site phacotrabeculectomy with mitomycin-C (phacotrabMMC) in glaucoma patients at increased risk for filtering surgery failure." | 3.73 | Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes. ( Damji, KF; Hodge, WG; Murthy, SK; Pan, Y, 2006) |
| "With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes." | 3.73 | Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006) |
| "To characterise changes in ocular dimensions after combined cataract operation and trabeculectomy with mitomycin C using separate incisions (combined operation)." | 3.73 | Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions. ( Caprioli, J; Law, SK; Mansury, AM; Vasudev, D, 2005) |
| "To present the clinical and histologic findings of a patient in whom intumescent cataract developed after successful topical mitomycin-C (MMC) chemotherapy for conjunctival melanoma originating from primary acquired conjunctival melanosis (PAM) with atypia." | 3.72 | Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. ( Horvat, R; Lukas, JR; Sacu, S; Ségur-Eltz, N; Zehetmayer, M, 2003) |
| "To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery." | 3.72 | Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery. ( Bagga, H; Gothwal, VK; Mandal, AK; Nanda, AK; Nutheti, R, 2003) |
| "Phacotrabeculectomy with intraoperative mitomycin C was successful in regard to both reduction of intraocular pressure and glaucoma medications." | 3.72 | Fornix vs limbus based flap in phacotrabeculetomy with mitomycin C: prospective study. ( Bencić, G; Bojić, L; Mandić, Z; Zorić Geber, M, 2004) |
| "02% mitomycin C (MMC) in glaucoma patients at risk for failure of filtration surgery." | 3.71 | Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. ( Casson, R; Rahman, R; Salmon, JF, 2001) |
| "A concurrent series (from January 1, 1987, to October 1, 1997) of one surgeon's consecutive 585 (456 patients) combined cataract extraction, intraocular lens implantation, and trabeculectomy surgeries, some with intraoperative mitomycin C and/or postoperative subconjunctival 5-fluorouracil." | 3.70 | Outcomes of combined cataract extraction, lens implantation, and trabeculectomy surgeries. ( Hahn, J; Larive, B; Rockwood, EJ, 2000) |
| "Retrospective analysis of all eyes that underwent phacoemulsification surgery for symptomatic cataracts and had a preoperative diagnosis of chronic hypotony (intraocular pressure [IOP] mitomycin C." | 3.70 | Effect of phacoemulsification surgery on hypotony following trabeculectomy surgery. ( Doyle, JW; Smith, MF, 2000) |
| "Twenty-nine consecutive eyes of 26 patients with cataract and glaucoma that had undergone combined phacoemulsification, posterior chamber lens implantation, and limbus-based trabeculectomy with mitomycin-C applied after the cataract removal and trabeculectomy had a minimal follow-up time of 12 months (mean follow-up 20 +/- 6." | 3.69 | Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure. ( Belyea, DA; Dan, JA; Lieberman, MF; Stamper, RL, 1997) |
| "We performed ultrasonography on a patient who, after trabeculectomy with mitomycin C, had an intraocular pressure of 1 mm Hg, an opaque cataract, and suspected hypotonous maculopathy in the left eye." | 3.69 | Echographic diagnosis of scleral fold in hypotony. ( DiBernardo, C; Loewenstein, A; McKinnon, S, 1997) |
| "Phacoemulsification combined with trabeculectomy using mitomycin-C appears to be an effective approach to the management of cataract in patients with glaucoma." | 3.69 | Combined phacoemulsification and trabeculectomy with mitomycin-C. ( Schuman, JS; Zacharia, PT, 1997) |
| "Patients with both cataract and glaucoma underwent combined mitomycin C trabeculectomy, extracapsular cataract extraction, and intraocular lens implantation." | 3.69 | One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. ( Bueche, MJ; Feuer, WJ; Grajewski, AL; Joos, KM; Palmberg, PF, 1995) |
| " Combined phacoemulsification and mitomycin C trabeculectomy appears to be safe and effective for treating selected patients with coexisting glaucoma and cataract." | 3.69 | Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery. ( Berestka, JS; Brown, SV, 1997) |
| "To prevent the development of secondary cataract, mitomycin C (MC, 0." | 3.69 | Prevention of secondary cataract by antimitotic drugs: experimental study. ( Alió, JL; Ismail, MM; Ruiz Moreno, JM, 1996) |
| "To determine whether there is increased risk to the corneal endothelium when mitomycin C is used in trabeculectomy surgery instead of fluorouracil, and whether these agents play a role in accelerating cataract formation." | 3.69 | Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment. ( Chaturvedi, N; Dreyer, EB; Zurakowski, D, 1995) |
| "The glaucoma triple procedure with adjunctive mitomycin C appears to be a safe and effective surgical technique for treating selected patients with coexisting cataract and glaucoma." | 3.69 | Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C. ( Alward, WL; Munden, PM, 1995) |
| "This study demonstrated that mitomycin has a significant inhibitory effect on secondary cataract formation (proliferation as well as fibrosis) in rabbits whereas heparin does not seem to have the same effectiveness." | 3.69 | Mitomycin against posterior capsular opacification: an experimental study in rabbits. ( Galand, AL; Haus, CM, 1996) |
| "The use of topical mitomycin (mitomycin-C) as a medical adjunct to pterygium and glaucoma surgery is increasing." | 3.68 | Serious complications of topical mitomycin-C after pterygium surgery. ( Foster, CS; Martin, NF; Pfister, RR; Rubinfeld, RS; Speaker, MG; Stein, RM; Stoleru, S; Talley, AR, 1992) |
| "In this pilot study with a small number of subjects, short-term outcomes suggest that subconjunctival bevacizumab is equally effective in reducing intraocular pressure with a better safety profile compared with MMC in the dosing schedule studied." | 2.77 | Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial. ( Ravindran, RD; Sengupta, S; Venkatesh, R, 2012) |
| "The mean intraocular pressures were significantly (P < ." | 2.69 | Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C. ( Bendel, RE; Hughes, BA; Juzych, MS; Kim, C; Lemon, LC; Shin, DH, 1998) |
| "Cataract and glaucoma are two very common conditions that frequently are coincident within the same patient." | 2.39 | Management of coincident glaucoma and cataract. ( Samuelson, TW, 1996) |
| "To determine the long-term outcomes of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C (MMC) for primary angle-closure glaucoma (PACG) and primary open-angle glaucoma (POAG) in an Asian population." | 1.46 | Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population. ( Aduan, J; Aquino, CM; Chee, LS; Chen, D; Chew, P; Koh, V; Sng, C, 2017) |
| "To determine the efficacy of safe surgery system trabeculectomy combined with manual small incision cataract surgery/phacoemulsification in primary glaucoma coexistent with cataract." | 1.42 | Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction. ( Agashe, A; Khandelwal, R; Khandelwal, RR; Majumdar, M; Raje, D; Rathi, A, 2015) |
| " There was similar frequency (<10%) of adverse events in both groups, and there were no complications directly related to the Ologen implant." | 1.39 | Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year. ( Aung, T; Hoh, ST; Htoon, HM; Narayanaswamy, A; Perera, SA; Seah, SK; Wong, TT, 2013) |
| "We report a case of suprachoroidal hemorrhage following removal of a releasable suture after combined phacoemulsification-trabeculectomy." | 1.34 | Suprachoroidal hemorrhage following removal of releasable suture after combined phacoemulsification-trabeculectomy. ( Eong, KG; Prashanth, S; Raman, GV; Sathyan, P; Singh, G, 2007) |
| "Diclofenac was less effective but also reduced PCO." | 1.31 | Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents. ( Emiroğlu, L; Güler, C; Ilker, SS; Kaynak, S; Kurt, E; Ozer, E; Oztürk, F, 2001) |
| " The optimal biocompatible dosage must be carefully determined by further investigation." | 1.31 | Prevention of posterior capsule opacification by retinoic acid and mitomycin. ( Güler, C; Ilker, SS; Inan, UU; Kaynak, S; Ozer, E; Oztürk, F, 2001) |
| "Mitomycin C could cause the degeneration of lens epithelial cells." | 1.31 | [The inhibitory effect of mitomycin C applied by intracapsular method on rabbit lens epithelial cells: an experimental study of after-cataract]. ( Huang, J; Liu, Y; Zheng, D; Zheng, H, 2001) |
| "Intraocular pressures were lower in the group that received MMC compared to the 5-FU group, but not in the group that did not receive antimetabolites, at all time intervals measured (P < ." | 1.30 | Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents. ( Budenz, DL; Gordon, J; Keates, EU; Piltz-Seymour, J; Pyfer, M; Singh, K, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 25 (25.00) | 18.2507 |
| 2000's | 41 (41.00) | 29.6817 |
| 2010's | 23 (23.00) | 24.3611 |
| 2020's | 11 (11.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichhpujani, P | 1 |
| Singla, E | 1 |
| Kalra, G | 1 |
| Bhartiya, S | 1 |
| Kumar, S | 1 |
| Monja-Alarcón, N | 1 |
| Perucho-Martínez, S | 1 |
| Buenasmañanas-Maeso, M | 1 |
| Toledano-Fernández, N | 1 |
| Almobarak, FA | 2 |
| Alharbi, AH | 2 |
| Aljadaan, I | 2 |
| Aldhibi, H | 1 |
| Tekcan, H | 1 |
| Mangan, MS | 1 |
| Alpogan, O | 1 |
| Imamoglu, S | 1 |
| Kose, AO | 1 |
| Ercalık, NY | 1 |
| Ibarz Barberá, M | 1 |
| Martínez-Galdón, F | 1 |
| Caballero-Magro, E | 1 |
| Rodríguez-Piñero, M | 1 |
| Tañá-Rivero, P | 1 |
| Gedde, SJ | 2 |
| Feuer, WJ | 3 |
| Lim, KS | 1 |
| Barton, K | 1 |
| Goyal, S | 2 |
| Ahmed, II | 1 |
| Brandt, JD | 1 |
| Wagner, FM | 1 |
| Schuster, AK | 1 |
| Kianusch, K | 1 |
| Stingl, J | 1 |
| Pfeiffer, N | 1 |
| Hoffmann, EM | 1 |
| Pathak Ray, V | 1 |
| Chaironika, N | 1 |
| Gupta, S | 1 |
| Choudhari, NS | 2 |
| Hamdi, MM | 1 |
| Hamdi, IM | 1 |
| Elksne, E | 1 |
| Mercieca, K | 3 |
| Prokosch-Willing, V | 1 |
| Mokkarala, AJR | 1 |
| Tone, B | 1 |
| Khanna, R | 1 |
| Garudadri, CS | 2 |
| Denkel, L | 1 |
| Hohberger, B | 1 |
| Lämmer, R | 1 |
| Vinod, K | 1 |
| Panarelli, JF | 1 |
| Chang, TC | 1 |
| Chen, PP | 1 |
| Parrish, RK | 1 |
| Perumal, D | 1 |
| Darcy, K | 1 |
| Anand, N | 4 |
| Paletta Guedes, RA | 1 |
| Gravina, DM | 1 |
| Paletta Guedes, VM | 1 |
| Chaoubah, A | 1 |
| Wlaź, A | 1 |
| Wilkos-Kuc, A | 1 |
| Rozegnał-Madej, A | 1 |
| Żarnowski, T | 1 |
| E Graf, N | 1 |
| Müller, M | 1 |
| Gerlach, F | 1 |
| M Meyer, L | 1 |
| Philipp, S | 1 |
| Distelmaier, P | 1 |
| Klink, T | 1 |
| Schönfeld, CL | 1 |
| Yuksel, D | 1 |
| Kosker, M | 1 |
| Reddy, JC | 1 |
| Celik, T | 1 |
| Ogata-Iwao, M | 1 |
| Inatani, M | 1 |
| Takihara, Y | 1 |
| Inoue, T | 1 |
| Iwao, K | 1 |
| Tanihara, H | 1 |
| Darian-Smith, E | 1 |
| Toh, T | 1 |
| Khandelwal, RR | 1 |
| Raje, D | 1 |
| Rathi, A | 1 |
| Agashe, A | 1 |
| Majumdar, M | 1 |
| Khandelwal, R | 1 |
| Chen, DZ | 1 |
| Koh, V | 3 |
| Sng, C | 2 |
| Aquino, MC | 1 |
| Chew, P | 2 |
| Na, JH | 1 |
| Sung, KR | 1 |
| Shin, JA | 1 |
| Moon, JI | 1 |
| Shevade, B | 1 |
| Tatsios, J | 1 |
| Chew, PT | 1 |
| Amrith, S | 1 |
| Pérez-Torregrosa, VT | 1 |
| Olate-Pérez, Á | 1 |
| Cerdà-Ibáñez, M | 1 |
| Gargallo-Benedicto, A | 1 |
| Osorio-Alayo, V | 1 |
| Barreiro-Rego, A | 1 |
| Duch-Samper, A | 1 |
| Chen, D | 1 |
| Aquino, CM | 1 |
| Aduan, J | 1 |
| Chee, LS | 1 |
| Morales, J | 1 |
| Tham, CC | 3 |
| Kwong, YY | 3 |
| Leung, DY | 3 |
| Lam, SW | 2 |
| Li, FC | 3 |
| Chiu, TY | 2 |
| Chan, JC | 2 |
| Chan, CH | 1 |
| Poon, AS | 1 |
| Yick, DW | 1 |
| Chi, CC | 1 |
| Lam, DS | 3 |
| Lai, JS | 2 |
| Nazm, N | 1 |
| Gandhi, M | 1 |
| Dubey, S | 1 |
| Pegu, J | 1 |
| Iyer, JV | 1 |
| Perera, SA | 2 |
| Aung, T | 2 |
| Rao, HL | 1 |
| Maheshwari, R | 1 |
| Senthil, S | 1 |
| Prasad, KK | 1 |
| Emarah, AM | 1 |
| El-Helw, MA | 1 |
| Sengupta, S | 1 |
| Venkatesh, R | 1 |
| Ravindran, RD | 1 |
| Levkovitch-Verbin, H | 2 |
| Katz, G | 1 |
| Kalev-Landoi, M | 1 |
| Goldenfeld, M | 1 |
| Baig, N | 1 |
| Narayanaswamy, A | 1 |
| Htoon, HM | 1 |
| Hoh, ST | 1 |
| Seah, SK | 1 |
| Wong, TT | 1 |
| Shin, DH | 7 |
| Iskander, NG | 1 |
| Ahee, JA | 1 |
| Singal, IP | 1 |
| Kim, C | 6 |
| Hughes, BA | 5 |
| Eliassi-Rad, B | 1 |
| Kim, YY | 2 |
| Kozobolis, VP | 1 |
| Siganos, CS | 1 |
| Christodoulakis, EV | 1 |
| Lazarov, NP | 1 |
| Koutentaki, MG | 1 |
| Pallikaris, IG | 1 |
| Jampel, HD | 1 |
| Friedman, DS | 1 |
| Lubomski, LH | 1 |
| Kempen, JH | 1 |
| Quigley, H | 1 |
| Congdon, N | 1 |
| Robinson, KA | 1 |
| Bass, EB | 1 |
| Zheng, D | 1 |
| Liu, Y | 1 |
| Huang, J | 1 |
| Zheng, H | 1 |
| Mandal, AK | 1 |
| Bagga, H | 1 |
| Nutheti, R | 1 |
| Gothwal, VK | 1 |
| Nanda, AK | 1 |
| Sacu, S | 1 |
| Ségur-Eltz, N | 1 |
| Horvat, R | 1 |
| Lukas, JR | 1 |
| Zehetmayer, M | 1 |
| Miyamoto, T | 1 |
| Saika, S | 1 |
| Okada, Y | 1 |
| Ishida-Nishikawa, I | 1 |
| Sumioka, T | 1 |
| Fujita, N | 1 |
| Ohnishi, Y | 1 |
| Mandić, Z | 1 |
| Bencić, G | 1 |
| Zorić Geber, M | 1 |
| Bojić, L | 1 |
| O'Brart, DP | 1 |
| Shiew, M | 1 |
| Edmunds, B | 1 |
| Pfister, RR | 2 |
| Alzafiri, Y | 1 |
| Harasymowycz, P | 1 |
| Fernandez, V | 1 |
| Fragoso, MA | 1 |
| Billotte, C | 1 |
| Lamar, P | 1 |
| Orozco, MA | 1 |
| Dubovy, S | 1 |
| Willcox, M | 1 |
| Parel, JM | 1 |
| Funnell, CL | 1 |
| Clowes, M | 1 |
| Landa, G | 1 |
| Pollack, A | 1 |
| Rachmiel, R | 1 |
| Bukelman, A | 1 |
| Marcovich, A | 1 |
| Zalish, M | 1 |
| Law, SK | 1 |
| Mansury, AM | 1 |
| Vasudev, D | 1 |
| Caprioli, J | 1 |
| Murthy, SK | 1 |
| Damji, KF | 1 |
| Pan, Y | 1 |
| Hodge, WG | 1 |
| Banitt, M | 1 |
| Juzych, MS | 4 |
| Chopra, V | 1 |
| Shingleton, BJ | 2 |
| Price, RS | 1 |
| O'Donoghue, MW | 2 |
| Li, G | 1 |
| Kasner, O | 1 |
| Park, UC | 1 |
| Ahn, JK | 1 |
| Park, KH | 1 |
| Yu, HG | 1 |
| Chakraborty, D | 1 |
| Dutta Choudhury, B | 1 |
| Kobayashi, H | 1 |
| Kobayashi, K | 1 |
| Anand, S | 1 |
| Sathyan, P | 2 |
| Singh, G | 1 |
| Eong, KG | 1 |
| Raman, GV | 1 |
| Prashanth, S | 1 |
| Cotran, PR | 1 |
| Roh, S | 1 |
| McGwin, G | 1 |
| Kim, SY | 1 |
| Kim, JH | 1 |
| Choi, JS | 1 |
| Joo, CK | 1 |
| Dreyer, EB | 1 |
| Chaturvedi, N | 1 |
| Zurakowski, D | 1 |
| Munden, PM | 1 |
| Alward, WL | 1 |
| Joos, KM | 1 |
| Bueche, MJ | 1 |
| Palmberg, PF | 1 |
| Grajewski, AL | 1 |
| Ismail, MM | 1 |
| Alió, JL | 1 |
| Ruiz Moreno, JM | 1 |
| Berestka, JS | 1 |
| Brown, SV | 1 |
| Haus, CM | 1 |
| Galand, AL | 1 |
| Simone, PA | 1 |
| Song, MS | 2 |
| Reed, SY | 2 |
| Belyea, DA | 1 |
| Dan, JA | 1 |
| Lieberman, MF | 1 |
| Stamper, RL | 1 |
| Yang, KJ | 2 |
| Moster, MR | 1 |
| Azuara-Blanco, A | 1 |
| Wilson, RP | 1 |
| Araujo, SV | 1 |
| Schmidt, CM | 1 |
| Tezel, G | 1 |
| Kolker, AE | 1 |
| Kass, MA | 1 |
| Wax, MB | 1 |
| Loewenstein, A | 1 |
| McKinnon, S | 1 |
| DiBernardo, C | 1 |
| Zacharia, PT | 1 |
| Schuman, JS | 1 |
| Nuijts, RM | 1 |
| Vernimmen, RC | 1 |
| Webers, CA | 1 |
| Lemon, LC | 2 |
| Bendel, RE | 1 |
| Ren, J | 2 |
| Glover, KB | 2 |
| Weatherwax, AL | 1 |
| Pearlman, RB | 1 |
| Muenk, SB | 1 |
| Daugeliene, L | 1 |
| Yamamoto, T | 1 |
| Sawada, A | 1 |
| Kitazawa, Y | 1 |
| Weene, LE | 1 |
| Derick, RJ | 1 |
| Evans, J | 1 |
| Baker, ND | 1 |
| Samuelson, TW | 3 |
| Budenz, DL | 1 |
| Pyfer, M | 1 |
| Singh, K | 1 |
| Gordon, J | 1 |
| Piltz-Seymour, J | 1 |
| Keates, EU | 1 |
| Gayton, JL | 1 |
| Van Der Karr, M | 1 |
| Sanders, V | 1 |
| Doyle, JW | 1 |
| Smith, MF | 1 |
| Ober, MD | 1 |
| Nootheti, P | 1 |
| Cha, SC | 1 |
| Kim, PH | 2 |
| Chung, HS | 1 |
| Lim, SJ | 1 |
| Kim, HB | 1 |
| Rockwood, EJ | 1 |
| Larive, B | 1 |
| Hahn, J | 1 |
| Casson, R | 1 |
| Rahman, R | 1 |
| Salmon, JF | 2 |
| Oztürk, F | 2 |
| Kaynak, S | 2 |
| Kurt, E | 1 |
| Emiroğlu, L | 1 |
| Ozer, E | 2 |
| Ilker, SS | 2 |
| Güler, C | 2 |
| Inan, UU | 1 |
| Casson, RJ | 1 |
| Vandenbelt, SM | 1 |
| Gross, JP | 1 |
| Keole, NS | 1 |
| Lee, SH | 1 |
| Birt, CM | 1 |
| Chaudhry, IM | 1 |
| Rubinfeld, RS | 1 |
| Stein, RM | 1 |
| Foster, CS | 1 |
| Martin, NF | 1 |
| Stoleru, S | 1 |
| Talley, AR | 1 |
| Speaker, MG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Macular Thickness in Patients With Glaucoma in Use of Topical Prostaglandin Analogue Undergoing Trabeculectomy With Mitomycin C[NCT06000280] | 37 participants (Actual) | Interventional | 2021-01-04 | Completed | |||
| Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)[NCT00494923] | 2,500 participants (Anticipated) | Observational | 1999-01-31 | Recruiting | |||
| Phaco-UCP; Combined Phacoemulsification and Ultrasound Ciliary Plasty Versus Phacoemulsification Alone for Management of Coexisting Cataract and Open Angle Glaucoma[NCT04430647] | 61 participants (Actual) | Interventional | 2018-03-01 | Completed | |||
| XEN45 Gel Stent Implantation in Glaucoma Surgery[NCT03138928] | 15 participants (Actual) | Observational | 2015-01-31 | Completed | |||
| Comparison of Combined Phacotrabeculectomy and Trabeculectomy Only in the Treatment of Primary Angle-closure Glaucoma[NCT01298635] | 31 participants (Actual) | Interventional | 2005-01-31 | Completed | |||
| Prospective Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma[NCT03323138] | 40 participants (Anticipated) | Interventional | 2012-07-01 | Recruiting | |||
| Effectiveness and Safety of Trabeculectomy and Peripheral Iridectomy Plus Goniotomy in Advanced Primary Angle-closure Glaucoma: a Multicenter Non-inferiority Randomized Controlled Trial[NCT05163951] | 88 participants (Anticipated) | Interventional | 2022-01-05 | Recruiting | |||
| Effectiveness and Safety of Phacotrabeculectomy and Phacogoniotomy in Advanced Primary Angle-closure Glaucoma: a Multicenter Randomized Controlled Trial[NCT04878458] | 124 participants (Actual) | Interventional | 2021-05-31 | Active, not recruiting | |||
| Combined Phacoemulsification and Viscocanalostomy With Ologen Implant Versus Combined Phacoemulsification and Viscocanalostomy[NCT03782051] | 81 participants (Actual) | Interventional | 2013-08-01 | Completed | |||
| Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy[NCT00695747] | 95 participants (Actual) | Interventional | 1998-01-31 | Completed | |||
| Modified Trabeculectomy With an Extended Subscleral Tunnel Versus Conventional Trabeculectomy for Management of Primary Open Angle Glaucoma (POAG)[NCT03480711] | 40 participants (Actual) | Interventional | 2018-07-10 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for mitomycin and Cataract, Membranous
| Article | Year |
|---|---|
Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review.
Topics: Antimetabolites, Antineoplastic; Cataract; Cataract Extraction; Evidence-Based Medicine; Fluorouraci | 2002 |
Mitomycin C primary trabeculectomy in primary glaucoma of white patients.
Topics: Antimetabolites; Cataract; Disease Progression; Glaucoma; Humans; Intraocular Pressure; Intraoperati | 1997 |
Management of coincident glaucoma and cataract.
Topics: Cataract; Cataract Extraction; Exfoliation Syndrome; Fluorouracil; Glaucoma; Humans; Lenses, Intraoc | 1995 |
Management of coincident glaucoma and cataract.
Topics: Cataract; Cataract Extraction; Chemotherapy, Adjuvant; Glaucoma; Humans; Mitomycin; Trabeculectomy | 1996 |
Management of coincident glaucoma and cataract.
Topics: Cataract; Cataract Extraction; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin; | 1999 |
Combined surgery in the treatment of patients with cataract and primary open-angle glaucoma.
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Mitomy | 2001 |
21 trials available for mitomycin and Cataract, Membranous
| Article | Year |
|---|---|
Postoperative Complications in the Primary Tube Versus Trabeculectomy Study During 5 Years of Follow-up.
Topics: Alkylating Agents; Blindness; Cataract; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Hum | 2022 |
Phacotrabeculectomy using collagen matrix implant (Ologen
Topics: Aged; Alkylating Agents; Cataract; Collagen; Drug Implants; Female; Follow-Up Studies; Glaucoma; Gly | 2019 |
Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions.
Topics: Cataract; Collagen; Combined Modality Therapy; Gels; Glaucoma Drainage Implants; Glaucoma, Open-Angl | 2016 |
Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2008 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Anterior lens capsule versus mitomycin-C as an adjunct to trabeculectomy in combined phacotrabeculectomy.
Topics: Aged; Alkylating Agents; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Lens Capsule, Cry | 2011 |
Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial.
Topics: Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Ca | 2012 |
Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C.
Topics: Administration, Topical; Aged; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Cataract; | 2013 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Two-site phacotrabeculectomy with intraoperative mitomycin-C: fornix- versus limbus-based conjunctival opening in fellow eyes.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intr | 2002 |
A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Blister; Cataract; Female; Filtering Surgery; Fluor | 2004 |
Comparison of 1-site versus 2-site phacotrabeculectomy.
Topics: Antihypertensive Agents; Case-Control Studies; Cataract; Fluorouracil; Follow-Up Studies; Glaucoma; | 2006 |
Randomized comparison of the intraocular pressure-lowering effect of phacoviscocanalostomy and phacotrabeculectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Catheterization; Chronic Disease; Female; Glau | 2007 |
Randomized comparison of 1-Site and 2-Site phacotrabeculectomy with 3-year follow-up.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cataract; Female; Follow-Up Studies; Glaucoma, Ope | 2008 |
Adjunctive subconjunctival mitomycin C in glaucoma triple procedure.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Conjunctiva; Female; Follow-Up | 1995 |
Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C.
Topics: Aged; Cataract; Chemotherapy, Adjuvant; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intraocul | 1998 |
Primary glaucoma triple procedure in patients with primary open-angle glaucoma: the effect of mitomycin C in patients with and without prognostic factors for filtration failure.
Topics: Aged; Cataract; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; Humans; Lens Implantation, Int | 1998 |
Decrease of capsular opacification with adjunctive mitomycin C in combined glaucoma and cataract surgery.
Topics: Aged; Aged, 80 and over; Cataract; Cataract Extraction; Chemotherapy, Adjuvant; Female; Glaucoma, Op | 1998 |
Combined phacoemulsification and trabeculectomy versus trabeculectomy alone: a comparison study using mitomycin-C.
Topics: Aged; Aged, 80 and over; Cataract; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure | 1998 |
Combined cataract and glaucoma surgery: trabeculectomy versus endoscopic laser cycloablation.
Topics: Cataract; Ciliary Body; Endoscopy; Female; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Intrao | 1999 |
Posterior capsular opacification in phacotrabeculectomy : a long-term comparative study of silicone versus acrylic intraocular lens.
Topics: Acrylic Resins; Adult; Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Female; Follow-Up | 2000 |
73 other studies available for mitomycin and Cataract, Membranous
| Article | Year |
|---|---|
Surgical trends in glaucoma management: The current Indian scenario.
Topics: Cataract; Child; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Trab | 2022 |
Does mitomycin-C concentration have any influence on XEN45 gel stent outcomes in a real-world setting?
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Sten | 2022 |
Phacoemulsification after trabeculectomy in uveitis associated with Vogt-Koyanagi-Harada disease: intermediate-term visual outcome, IOP control and trabeculectomy survival.
Topics: Cataract; Humans; Intraocular Pressure; Mitomycin; Phacoemulsification; Retrospective Studies; Trabe | 2022 |
The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy.
Topics: Cataract; Exfoliation Syndrome; Glaucoma; Humans; Intraocular Pressure; Lens Implantation, Intraocul | 2022 |
Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.
Topics: Antihypertensive Agents; Cataract; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mit | 2022 |
Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study.
Topics: Cataract; Eye; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Ret | 2023 |
New superior modified fornix-based twin-site phacotrabeculectomy.
Topics: Antibiotics, Antineoplastic; Cataract; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Mitomy | 2019 |
The role of mitomycin C and porcine extracellular matrix in phacotrabeculectomy.
Topics: Adult; Aged; Alkylating Agents; Cataract; Collagen; Drug Combinations; Female; Glaucoma, Open-Angle; | 2021 |
Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation.
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Trabecul | 2022 |
Modifications to Combined Trabeculectomy and Manual Small Incision Cataract Surgery: Outcomes and Adaptability in Resource-constrained Areas.
Topics: Adult; Aged; Cataract; Follow-Up Studies; Humans; Intraocular Pressure; Mitomycin; Ophthalmology; Re | 2021 |
Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients.
Topics: Cataract; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; | 2021 |
Practice Preferences for Glaucoma Surgery: A Survey of the American Glaucoma Society.
Topics: Alkylating Agents; Cataract; Female; Filtering Surgery; Fluorouracil; Glaucoma Drainage Implants; Gl | 2017 |
Cataract extraction after deep sclerectomy and its effect on intraocular pressure control.
Topics: Age Factors; Aged; Analysis of Variance; Cataract; Cataract Extraction; Female; Humans; Intraocular | 2019 |
Use of a Collagen Matrix Implant as an Adjuvant in Combined Surgery Involving Phacoemulsification and Nonpenetrating Deep Sclerectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Collagen; Exfoliation Syndrome; Female; Glauco | 2019 |
Comparison of 2-year-results of mitomycin C-augmented trabeculectomy with or without cataract extraction in glaucoma patients.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Female; Follow-Up Studies; Glaucoma; | 2019 |
Management of cataracts and oculo-cutaneous malignancy in xeroderma pigmentosum.
Topics: Adolescent; Biological Dressings; Carcinoma, Squamous Cell; Cataract; Conjunctival Neoplasms; Female | 2013 |
A prospective comparison between trabeculectomy with mitomycin C and phacotrabeculectomy with mitomycin C.
Topics: Aged; Alkylating Agents; Cataract; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intra | 2013 |
Corneal decompensation following bleb needling with 0.01% mitomycin C: a case study.
Topics: Aged; Alkylating Agents; Cataract; Combined Modality Therapy; Conjunctiva; Corneal Edema; Female; Gl | 2014 |
Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction.
Topics: Alkylating Agents; Cataract; Cataract Extraction; Female; Glaucoma, Angle-Closure; Glaucoma, Open-An | 2015 |
Complications and outcomes of primary phacotrabeculectomy with mitomycin C in a multi-ethnic asian population.
Topics: Aged; Asian People; Cataract; Cataract Extraction; Female; Glaucoma, Angle-Closure; Glaucoma, Open-A | 2015 |
Antifibrotic effects of pirfenidone on Tenon's fibroblasts in glaucomatous eyes: comparison with mitomycin C and 5-fluorouracil.
Topics: Actins; Adult; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Catara | 2015 |
Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Female; Glaucoma; Humans; Intraocular Pressure | 2015 |
Comparison of incidence of ptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification.
Topics: Aged; Alkylating Agents; Blepharoptosis; Cataract; Combined Modality Therapy; Female; Glaucoma; Huma | 2015 |
Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population.
Topics: Aged; Cataract; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; In | 2017 |
The Influence of Phacoemulsification on Intraocular Pressure Control and Trabeculectomy Survival in Uveitic Glaucoma.
Topics: Adult; Alkylating Agents; Antihypertensive Agents; Case-Control Studies; Cataract; Female; Glaucoma, | 2017 |
Angle closure glaucoma.
Topics: Antihypertensive Agents; Cataract; Chronic Disease; Glaucoma, Angle-Closure; Humans; Intraocular Pre | 2009 |
Phacoemulsification and glaucoma.
Topics: Antihypertensive Agents; Cataract; Chronic Disease; Glaucoma, Angle-Closure; Humans; Intraocular Pre | 2009 |
Phacotrabeculectomy without mitomycin C in primary angle-closure and open-angle glaucoma.
Topics: Alkylating Agents; Antihypertensive Agents; Cataract; Female; Follow-Up Studies; Glaucoma, Angle-Clo | 2011 |
Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year.
Topics: Absorbable Implants; Aged; Alkylating Agents; Cataract; Collagen; Female; Glaucoma; Glycosaminoglyca | 2013 |
Long-term filtration and visual field outcomes after primary glaucoma triple procedure with and without mitomycin-C.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans | 2002 |
[The inhibitory effect of mitomycin C applied by intracapsular method on rabbit lens epithelial cells: an experimental study of after-cataract].
Topics: Animals; Antimetabolites, Antineoplastic; Cataract; Epithelial Cells; Female; Follow-Up Studies; Int | 2001 |
Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.
Topics: Adolescent; Aphakia, Postcataract; Cataract; Cataract Extraction; Chemotherapy, Adjuvant; Child; Chi | 2003 |
Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Cataract; Cataract Extraction; Conjunctival Ne | 2003 |
Topical exposure of mitomycin C reduces opacification of the residual anterior lens capsule and lenticular regeneration after vitrectomy and lensectomy in rabbits.
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Cataract; Epithelial Cells; Lens Caps | 2004 |
Fornix vs limbus based flap in phacotrabeculetomy with mitomycin C: prospective study.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intr | 2004 |
Permanent corneal edema resulting from the treatment of PTK corneal haze with mitomycin: a case report.
Topics: Adult; Cataract; Corneal Edema; Corneal Surgery, Laser; Humans; Keratoplasty, Penetrating; Male; Mit | 2004 |
Foldable acrylic versus rigid polymethylmethacrylate intraocular lens in combined phacoemulsification and trabeculectomy.
Topics: Aged; Antibiotics, Antineoplastic; Biocompatible Materials; Cataract; Glaucoma; Hospitals, Universit | 2004 |
Efficacy of various drugs in the prevention of posterior capsule opacification: experimental study of rabbit eyes.
Topics: Acetates; Acetic Acid; Animals; Capsulorhexis; Cataract; Cell Proliferation; Drug Combinations; Edet | 2004 |
Combined cataract and glaucoma surgery with mitomycin C: phacoemulsification-trabeculectomy compared to phacoemulsification-deep sclerectomy.
Topics: Aged; Cataract; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular Pressure; Intraoper | 2005 |
Results of combined phacoemulsification and trabeculectomy with mitomycin C in pseudoexfoliation versus non-pseudoexfoliation glaucoma.
Topics: Aged; Cataract; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intra | 2005 |
Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions.
Topics: Aged; Aged, 80 and over; Biometry; Cataract; Cornea; Eye; Female; Glaucoma; Humans; Intraocular Pres | 2005 |
Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes.
Topics: Adult; Antibiotics, Antineoplastic; Cataract; Follow-Up Studies; Glaucoma; Humans; Intraocular Press | 2006 |
The effect of the timing of scleral flap suture release on the safety and long-term success of phacotrabeculectomy.
Topics: Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Glaucoma, Open-Angle; Humans; Lens Im | 2006 |
Review of consecutive phacotrabeculectomies supplemented with early needle revision and antimetabolites.
Topics: Aged; Aged, 80 and over; Antimetabolites; Cataract; Female; Fluorouracil; Glaucoma; Humans; Intraocu | 2006 |
Phacotrabeculectomy with mitomycin C in patients with uveitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Alkylating Agents; Case-Control Studies; Cataract; Co | 2006 |
Phacotrabeculectomy study.
Topics: Alkylating Agents; Antihypertensive Agents; Cataract; Fluorouracil; Glaucoma; Humans; Intraocular Pr | 2007 |
Combined phacoemulsification and deep sclerectomy (PDS) with intraoperative mitomycin C (MMC) augmentation.
Topics: Aged; Aged, 80 and over; Cataract; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular | 2008 |
Consultation section: cataract surgical problem.
Topics: Anisometropia; Anterior Chamber; Cataract; Choroid Diseases; Combined Modality Therapy; Female; Glau | 2007 |
Suprachoroidal hemorrhage following removal of releasable suture after combined phacoemulsification-trabeculectomy.
Topics: Aged; Alkylating Agents; Cataract; Choroid Hemorrhage; Combined Modality Therapy; Exfoliation Syndro | 2007 |
Comparison of posterior capsule opacification in rabbits receiving either mitomycin-C or distilled water for sealed-capsule irrigation during cataract surgery.
Topics: Animals; Antimetabolites; Cataract; Lens Capsule, Crystalline; Mitomycin; Phacoemulsification; Rabbi | 2007 |
Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment.
Topics: Aged; Anterior Eye Segment; Cataract; Cell Count; Chemotherapy, Adjuvant; Female; Fluorouracil; Glau | 1995 |
Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Female; Follow-Up Studies; Glaucoma; | 1995 |
One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction.
Topics: Adult; Aged; Astigmatism; Cataract; Cataract Extraction; Female; Fluorouracil; Follow-Up Studies; Gl | 1995 |
Prevention of secondary cataract by antimitotic drugs: experimental study.
Topics: Animals; Antineoplastic Agents; Cataract; Cataract Extraction; Cell Count; Fluorouracil; Lens Capsul | 1996 |
Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery.
Topics: Aged; Cataract; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Lens | 1997 |
Mitomycin against posterior capsular opacification: an experimental study in rabbits.
Topics: Animals; Cataract; Cataract Extraction; Mitomycin; Postoperative Complications; Postoperative Period | 1996 |
Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma; Humans; Intraocula | 1997 |
Mitomycin-C supplemented trabeculectomy, phacoemulsification, and foldable lens implantation.
Topics: Aged; Cataract; Cataract Extraction; Equipment Design; Female; Humans; Intraocular Pressure; Lenses, | 1997 |
Comparative results of combined procedures for glaucoma and cataract: II. Limbus-based versus fornix-based conjunctival flaps.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Follow-Up | 1997 |
Echographic diagnosis of scleral fold in hypotony.
Topics: Cataract; Diagnosis, Differential; Eye Foreign Bodies; Female; Humans; Intraocular Pressure; Middle | 1997 |
Combined phacoemulsification and trabeculectomy with mitomycin-C.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Female; Foll | 1997 |
An image analysis study of cataract development after trabeculectomy with mitomycin C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma, Open-Angle; | 1998 |
Primary glaucoma triple procedure in patients with primary open-angle glaucoma.
Topics: Cataract; Cataract Extraction; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens Implantation | 1998 |
Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents.
Topics: Aged; Cataract; Chemotherapy, Adjuvant; Fibrosis; Fluorouracil; Glaucoma; Humans; Intraocular Pressu | 1999 |
Effect of phacoemulsification surgery on hypotony following trabeculectomy surgery.
Topics: Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Chronic Disease; Female; Glaucoma; Humans | 2000 |
Effect of mitomycin-C on posterior capsule opacification in rabbit eyes.
Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Cataract; Cell Division; Drug Combinat | 2000 |
Outcomes of combined cataract extraction, lens implantation, and trabeculectomy surgeries.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Cataract; Cataract Extraction; Female; | 2000 |
Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure.
Topics: Aged; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Macula Lutea; Male; Middle Aged; Mit | 2001 |
Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents.
Topics: Animals; Cataract; Dexamethasone; Diclofenac; Drug Therapy, Combination; Edetic Acid; Epithelial Cel | 2001 |
Prevention of posterior capsule opacification by retinoic acid and mitomycin.
Topics: Animals; Antimetabolites; Cataract; Cell Division; Epithelial Cells; Intraoperative Period; Lens Cap | 2001 |
Comparison of long-term incidence of posterior capsular opacification between phacoemulsification and phacotrabeculectomy.
Topics: Aged; Antimetabolites; Case-Control Studies; Cataract; Female; Glaucoma, Open-Angle; Humans; Inciden | 2002 |
Phacotrabeculectomy: peripheral iridectomy or no peripheral iridectomy?
Topics: Aged; Aged, 80 and over; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Iris; Lens Implan | 2002 |
Serious complications of topical mitomycin-C after pterygium surgery.
Topics: Adult; Aged; Calcinosis; Cataract; Contraindications; Corneal Diseases; Eye Diseases; Female; Humans | 1992 |